Best Medical Stocks To Buy Right Now


Health care stocks are performing better this year than investors might think, given the rancorousdebate over the Republicanplan to repeal and replace Obamacare.

Overall, the 61 stocks in the Standard & Poor’s 500 health care sector — which include hospitals, insurers, drug makers, biotechsand medical device makers –have gained8.9% in 2017 versus a 6%rise for the broadstock-market gauge, making it this year’s second-best performing group behind technology, says S&P Dow Jones Indices.At the same time last year, the sector was down 7.1%, compared witha 0.3% gain for the S&P 500.


So what’s injecting adrenaline into the stocks?

.oembed-asset-photo-image { width: 100%; }

Money managers who run health care funds say the group is rebounding from a poor2016 after being a market leader the five prior years. Since the enactment of the Affordable Care Act in March 2010, health care stocks have risen more than 133%, better than the S&P 500’s 103% gain. The group ran into trouble last year whenthe stocks got too pricey. That made themvulnerable to political attacks during the presidential campaign, when then-front-runner Hillary Clinton called out drug makers for “outrageous and unjustified pricing practices” and Donald Trump made it clear he planned to do away with the ACA.

Best Medical Stocks To Buy Right Now: Jacobs Engineering Group Inc.(JEC)


Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was Jacobs Engineering Group Inc. (NYSE: JEC) which rose about 9% to $64.92. The stocks 52-week range is $49.31 to $65.29. Volume was1.8 million compared to its average volume of less than 1 million.

  • [By Ben Levisohn]

    Lee offers 22 stocks that could benefit from the correlation trade: Western Digital (WDC), Xerox (XRX), First Solar, Ford Motor, Best Buy (BBY), PulteGroup (PHM), AutoNation (AN), Textron (TXT), Jacobs Engineering Group (JEC), Mosaic, BB&T (BBT), Fifth Third Bancorp (FITB),Loews (L), Regions Financial (RF), KeyCorp (KEY), Comerica (CMA), Leucadia National (LUK), Zions Bancorp (ZION), Valero Energy (VLO), Marathon Oil, Cardinal Health (CAH), and Pepco Holdings (POM).

Best Medical Stocks To Buy Right Now: Cabot Oil & Gas Corporation(COG)


Advisors’ Opinion:

  • [By Paul Ausick]

    Cabot Oil & Gas Corp. (NYSE: COG) is rated as a Hold with a new price target of $24. The EPS estimate has been cut from $0.60 to $0.47 for 2017, and the 2018 estimate has been increased from $0.70 to $1.19. Shares closed at $22.36 on Friday in a 52-week range of $19.77 to $25.74. The consensus 12-month price target is $28.72.

  • [By David Sterman]

    Take Cabot Oil & Gas (NYSE: COG(link is external)) as an example. As I noted earlier this month(link is external), Cabot’s current drilling plans are expected to lead to a big spike in output over the next few years. The company’s executives decided to plow ahead with development plans, even as rivals were retrenching. The fact that natural gas prices have risen more than 10% in the past three weeks simply underscores the wisdom of that strategy, and could lead to rising sales and profit estimates. 

Best Medical Stocks To Buy Right Now: Rite Aid Corporation(RAD)


Advisors’ Opinion:

  • [By Peter Graham]

    The Q3 2017 earnings report formid cap retail drugstore stock Rite Aid Corporation (NYSE: RAD) is scheduled forbefore the market opens on Thursday (December 22nd). We had Rite Aid Corporation (along with Walgreens)in our SmallCap Network Elite Opportunity (SCN EO) portfolio in the past as a turnaround bet thatcould eventually become a takeover target which proved correct as in October 2015, a definitive agreement was announced where Walgreens Boots Alliance Inc (NASDAQ: WBA) will acquire all outstanding shares of RAD for $9.00 per share in cash or approximately $17.2 billion – pending regulatory and shareholder approval.

  • [By Dan Caplinger]

    The stock market had a negative tone on Wednesday, although major benchmarks moved in different directions. The Dow Jones Industrials took the biggest hit, falling triple digits as one of its most influential components suffered an earnings-related drop. Relative strength in the Nasdaq Composite showed cross-currents in the overall market, but several individual stocks had substantial declines for the day, andRite Aid (NYSE:RAD), Diana Shipping (NYSE:DSX), and Finisar (NASDAQ:FNSR) were among the worst performers. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Rick Munarriz]

    It’s been a rough year forRite Aid(NYSE:RAD), and we’re only in early February. Shares of the drugstore chain plunged 23.7% last week, tumbling after Walgreens Boots Alliance(NASDAQ:WBA) amended its pending buyout agreement. Rite Aid stock has now surrendered 36% of its value in 2017.

  • [By Paul Ausick]

    Rite Aid Corp. (NYSE: RAD) dropped about 2.1% Tuesday to post a new 52-week low of $1.84 after closing at $1.89 on Monday. The stock’s 52-week high is $8.77. Volume of around 38 million was about 25% above the daily average. The company had no specific news.

Best Medical Stocks To Buy Right Now: Potash Corporation of Saskatchewan Inc.(POT)


Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers

    Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.

    Agri-Finance Companies

  • [By Ben Levisohn]

    We also want to reiterate our bullish view on the agricultural commodities and the ag-related stocks (e.g., CF Industries Holdings (CF), Mosaic (MOS), Potash Corp. of Saskatchewan (POT), FMC (FMC), AGCO, Deere). Following sharp multi-year declines, trends continue to improve.

Best Medical Stocks To Buy Right Now: PetMed Express, Inc.(PETS)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap pet stockPetmed Express Inc (NASDAQ: PETS) reportedQ2 earnings before the market opened this morning with shares soaring this morning as earnings were well beyond expectations. Net sales increased 10% to $66.7 million as new order sales increased 9% to $11.6 million while the Company’s online sales for the quarter ended September 30, 2017 were approximately 84% of all sales compared to 82% for the same quarter the prior year (with online sales increasing 12%). Net income was $8.8 million versusnet income of $4.9 million. The CEO commented:

  • [By Peter Graham]

    A long term performance chart shows Blue Buffalo Pet Products now roughly back up to its IPO close for retail investors while fresh pet food peer Freshpet Inc (NASDAQ: FRPT) is well below IPO levels and pet stocksCentral Garden & Pet Co (NASDAQ: CENT) andPetmed Express (NASDAQ: PETS) have been the best performers in the pet sector after PetSmart (NASDAQ: PETM) was acquired by a private equity group:

  • [By Lisa Levin] Gainers Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial. Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash. Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday. Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results. SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest. Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560. One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18. Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017. ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72 Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday. Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake. Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday. VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance. CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform. Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval. Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11